REVELIO THERAPEUTICS Trademark
Trademark Overview
On Tuesday, June 18, 2024, a trademark application was filed for REVELIO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the REVELIO THERAPEUTICS trademark a serial number of 98606663. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, January 10, 2025. This trademark is owned by Revelio Therapeutics, Inc.. The REVELIO THERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Therapeutic antibodies for the treatment of cancer; antibody therapeutic preparations for medical purposes for the treatment of cancer; biopharmaceutical preparations for the treatment of cancer
Antibodies for scientific and research purposes
Scientific research and development services in the field of therapeutic antibodies; research and development of technology in the fields of therapeutic antibodies and biopharmaceuticals
General Information
| Serial Number | 98606663 |
| Word Mark | REVELIO THERAPEUTICS |
| Filing Date | Tuesday, June 18, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Friday, January 10, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Therapeutic antibodies for the treatment of cancer; antibody therapeutic preparations for medical purposes for the treatment of cancer; biopharmaceutical preparations for the treatment of cancer |
| Goods and Services | Antibodies for scientific and research purposes |
| Goods and Services | Scientific research and development services in the field of therapeutic antibodies; research and development of technology in the fields of therapeutic antibodies and biopharmaceuticals |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 18, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 18, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 18, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Revelio Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
Trademark Events
| Event Date | Event Description |
| Tuesday, June 18, 2024 | NEW APPLICATION ENTERED |
| Thursday, January 9, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 10, 2025 | ASSIGNED TO EXAMINER |
| Friday, January 10, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, January 10, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, January 10, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
